Ana Foster – PharmaMedic

The role of regulatory affairs in enabling innovation

As 2021 gets underway, in the context of continued pandemic response and post-Brexit environment, the role of regulatory affairs in pharma is likely to be more instrumental than ever. In this article, we share a preview of the key regulatory trends that Dr Zubair Hussain will discuss at our upcoming breakfast briefing on the 10th February. Read on to learn more about the ways regulatory affairs is set to underpin innovation and sign up to attend our virtual briefing.

26 Jan 2021

London Bioscience Innovation Centre (LBIC) five years on

We marked our 5-year anniversary as a client of the London Bioscience Innovation Centre (LBIC) recently and featured in its Winter newsletter alongside Prokarium, MicrosensDx and VirTus and others.

11 Jan 2021

Year-end Round-Up – Your favourite PharmaMedic articles of 2020

2020 was certainly one of the most unusual years we can recall. Thank you to our clients, consultants and readers for following our news stories. We wrote on a range of topics and we recap the most widely read articles of last year in this short read.

4 Jan 2021

PharmaMedic announces Virtual Breakfast Briefing on 10th February 2021

PharmaMedic is delighted to announce the launch of a new series of virtual events starting with a breakfast briefing on Wednesday 10th February 2021 at 08:00 am. In this first event, we will cover the 2021 Medical and Regulatory Affairs Outlook. For full details and how to register please read further.

15 Dec 2020

Congratulations to Takeda UK and Makara Health on their recognition at the PMEA Awards

PharmaMedic was delighted to support and sponsor the Excellence in Rare Diseases and Orphan Drugs category at the recent PMEA awards. Read our article to find out more.

30 Nov 2020

Client Q&A: Dr Kathrine Scott, Gedeon Richter

In our latest article, we explore how PMC supports Dr Kathrine Scott of Gedeon Richter with new product launches and day to day copy approval. Read on to learn how we are helping this small medical team make a real impact.

24 Nov 2020

Building a brighter future for rare disease patients

The number of clinical trials for orphan conditions has grown significantly in the past decade. New advances in genomics and artificial intelligence also stand to improve prospects for patients with rare diseases. Read the article to learn how PharmaMedic helps translate often complex science into stakeholder value for rare disease sponsors and deliver new medicines to patients who need them.

12 Nov 2020

PMC® Announces Sponsorship of PMLiVE Pharmaceutical Market Excellence Awards

PharmaMedic Consultancy is delighted to announce its sponsorship of the ‘Excellence in Rare Diseases and Orphan Drugs" category at the 2020 Pharmaceutical Market Excellence Awards (PMEA).

30 Sep 2020

An independent future for the MHRA

From 1 January 2021, the Medicines and Healthcare products Regulatory Agency (MHRA) will be making independent regulatory decisions. Guidelines are in place, and the ABPI has called for support to help sponsors navigate the changes. Read on to learn more about this new era of independence for the agency.

9 Sep 2020

Client Q&A: Olivia Marsh, Glenmark Pharmaceuticals

In our latest article, we explore how PharmaMedic Consultancy (PMC®) supports Glenmark Pharmaceuticals with their day to day promotional activities. Read on to learn how our medical affairs consultant seamlessly fits into our client's team and ensures commercial compliance.

12 Aug 2020